CTLA4 and ovarian cancer: In the ID8 ovarian cancer model, tumor-infiltrating Tregs – which express both CTLA-4 and PD-1 – are reduced upon CTLA-4 and PD-1 dual blockade coinciding with increased tumor-infiltrating CD8+ T cells (137).